epinephrine insulin
Name
il6
Label
Il-6
Units
pg/mL
Type
numeric
Visit number vs Il-6
N Mean StdDev Median Min Max Unknown Total
Baseline 49 7.6 ± 20.0 3.4 1.6 138.5 - 49
9-Month Followup 43 10.0 ± 39.7 3.3 1.1 264.0 - 43
18-Month Followup 39 7.1 ± 22.5 2.8 0.8 143.2 1 40
Randomized treatment arm vs Il-6
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 7.6 ± 20.0 3.4 1.6 138.5 - 49
Laparoscopic Gastric Banding (LGB) 28 9.7 ± 26.3 3.3 1.6 138.5 - 28
Continuous Positive Airway Pressure (CPAP) 21 4.8 ± 3.0 3.5 1.7 11.6 - 21
Randomized treatment arm vs Il-6
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 10.0 ± 39.7 3.3 1.1 264.0 - 43
Laparoscopic Gastric Banding (LGB) 25 14.0 ± 52.1 3.3 1.6 264.0 - 25
Continuous Positive Airway Pressure (CPAP) 18 4.4 ± 3.1 3.1 1.1 11.8 - 18
Randomized treatment arm vs Il-6
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 7.1 ± 22.5 2.8 0.8 143.2 1 40
Laparoscopic Gastric Banding (LGB) 23 9.4 ± 29.2 2.4 1.5 143.2 1 24
Continuous Positive Airway Pressure (CPAP) 16 3.9 ± 2.2 3.8 0.8 8.4 - 16
Age of the participant vs Il-6
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 7.6 ± 20.0 3.4 1.6 138.5 - 49
27.0 to 45.0 years 13 3.8 ± 2.5 3.2 1.9 11.6 - 13
46.0 to 50.0 years 12 6.5 ± 11.4 3.1 1.6 42.0 - 12
51.0 to 56.0 years 12 4.4 ± 1.8 3.6 2.3 7.6 - 12
57.0 to 65.0 years 12 16.0 ± 38.7 4.4 1.7 138.5 - 12
Age of the participant vs Il-6
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 10.0 ± 39.7 3.3 1.1 264.0 - 43
28.0 to 47.0 years 11 3.2 ± 2.1 2.5 1.1 7.7 - 11
47.0 to 52.0 years 11 3.7 ± 2.9 2.7 1.4 11.8 - 11
52.0 to 58.0 years 11 5.0 ± 2.6 4.4 1.9 9.6 - 11
58.0 to 65.0 years 10 30.0 ± 82.3 3.9 1.6 264.0 - 10
Age of the participant vs Il-6
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 7.1 ± 22.5 2.8 0.8 143.2 1 40
29.0 to 46.0 years 10 3.0 ± 1.8 2.2 0.8 6.2 - 10
47.0 to 52.0 years 10 2.9 ± 1.2 2.3 1.8 4.8 - 10
53.0 to 58.0 years 10 4.2 ± 2.3 3.7 1.6 8.4 - 10
58.0 to 65.0 years 9 19.6 ± 46.4 3.9 1.5 143.2 1 10
Gender of the participant vs Il-6
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 7.6 ± 20.0 3.4 1.6 138.5 - 49
Male 28 3.9 ± 2.6 3.3 1.6 11.6 - 28
Female 21 12.5 ± 30.1 4.4 1.7 138.5 - 21
Gender of the participant vs Il-6
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 10.0 ± 39.7 3.3 1.1 264.0 - 43
Male 25 3.6 ± 2.1 2.6 1.1 8.7 - 25
Female 18 19.0 ± 61.2 3.7 1.9 264.0 - 18
Gender of the participant vs Il-6
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 7.1 ± 22.5 2.8 0.8 143.2 1 40
Male 24 3.3 ± 1.8 2.5 0.8 7.0 1 25
Female 15 13.3 ± 36.0 2.9 1.6 143.2 - 15
Race of the participant vs Il-6
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 46 7.8 ± 20.6 3.4 1.6 138.5 - 46
white 35 8.0 ± 22.8 3.5 1.6 138.5 - 35
american indian or alaska native - - - - - - - -
black or african american 9 8.2 ± 12.9 3.3 1.9 42.0 - 9
asian 2 2.6 ± 1.0 2.6 1.9 3.3 - 2
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Il-6
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 40 10.5 ± 41.2 3.3 1.1 264.0 - 40
white 31 12.1 ± 46.8 3.3 1.6 264.0 - 31
american indian or alaska native - - - - - - - -
black or african american 8 5.6 ± 4.0 4.5 1.4 11.8 - 8
asian 1 1.1 - 1.1 1.1 1.1 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Il-6
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 36 7.4 ± 23.4 2.8 0.8 143.2 1 37
white 29 8.1 ± 26.0 2.7 1.6 143.2 - 29
american indian or alaska native - - - - - - - -
black or african american 6 5.3 ± 3.5 4.8 1.5 10.4 1 7
asian 1 0.8 - 0.8 0.8 0.8 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -